Pharmacodynamics of macrolides, azalides, and streptogramins: Effect on extracellular pathogens

Clinical Infectious Diseases

Volumn 27, Issue 1, 1998, Pages 28-32

  Carbon, Claude ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZALIDE ANTIBIOTIC; AZITHROMYCIN; CLARITHROMYCIN; DIRITHROMYCIN; ERYTHROMYCIN; ERYTHROMYCIN A CYCLIC 11,12 CARBONATE; FLURITHROMYCIN; JOSAMYCIN; KITASAMYCIN; MACROLIDE; MIDECAMYCIN; MIOKAMYCIN; OLEANDOMYCIN; ROKITAMYCIN; ROXITHROMYCIN; SPIRAMYCIN; STREPTOGRAMIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; BACTERIAL INFECTION; CHRONOTHERAPY; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; GRAM POSITIVE COCCI; MOUSE; NONHUMAN; PH; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0031857650     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514619     Document Type: Conference Paper

References (9)

1. Kirst HA. New macrolides expand horizons of an old class of antibiotics. J Antimicrob Chemother 1991;28:787-90.
2. Bryskier A. Newer macrolides and their potential target organisms. Curr Opin Infect Dis. 1992;5:764-72.
3. Bouanchaud D. In vitro and in vivo synergic activity and fractional inhibitory concentration of the components of a semi-synthetic streptogramin, RP 59500. J Antimicrob Chemother 1992;30(suppl A):95-9.
4. Bryskier A, Agouridas C, Gasc JC. Classification of macrolide antibiotics. In: Bryskier A, Butzler JP, Neu HC, Tulkens MP, eds. Macrolides: chemistry, pharmacology, and clinical use. Oxford, England: Blackwell, 1993:5-66.
5. Lode H, Boechk M, Schaberg T, Borner K, Koeppe P. Pharmacology of macrolides. In: Neu HC, Young LS, Zinner SH, eds. The new macrolides, azalides, and streptogramins. New York: Marcel Dekker, 1993: 61-8.
6. Bechtol LD, Stephens VC, Pugh CT, et al. Erythromycin esters: comparative in vivo hydrolysis and bioavailability. Curr Ther Res 1976;20: 610-22.
7. Etienne SD, Montay G, Le Liboux A, Frydman A, Garaud JJ. A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500. J Antimicrob Chemother 1992;30(suppl A):123-31.
8. Neu HC. Activity of macrolides against common pathogens in vitro. In: Bryskier A, Butzler JP, Neu HC, Tulkens MP, eds. Macrolides: chemistry, pharmacology, and clinical use. Oxford, England: Blackwell, 1993: 167-82.
9. Fantin B, Leclercq R, Ottaviani M, et al. In vivo activity and penetration of the two components of the streptogramin RP59500 in cardiac vegetations of experimental endocarditis. Antimicrob Agents Chemother 1994; 38:432-7.